0

Purchase Short-Term Access

Potential Cost-Effectiveness of Prophylactic Use of the Implantable Cardioverter Defibrillator or Amiodarone after Myocardial Infarction
Gillian D. Sanders, PhD; Mark A. Hlatky, MD; Nathan R. Every, MD, MPH; Kathryn M. McDonald, MM; Paul A. Heidenreich, MD, MS; Lori S. Parsons, BS; Douglas K. Owens, MD, MS
Annals of Internal Medicine 2001;135:870-883. doi:10.7326/0003-4819-135-10-200111200-00007

Purchase Online access to this article for 24 hours
Buy Now

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)